참고문헌
- Nakagama, H. (2010) PPARgamma and cancer. Nippon Rinsho. 68: 323-9.
- Lyon, C. M., D. M. Klinge, K. C. Do, M. J. Grimes, C. L. Thomas, L. A. Damiani, T. H. March, C. A. Stidley, and S. A. Belinsky (2009) Rosiglitazone prevents the progression of preinvasive lung cancer in a murine model. Carcinogenesis 30: 2095-9. https://doi.org/10.1093/carcin/bgp260
- Yu, J., B. Shen, E. S. Chu, N. Teoh, K. F. Cheung, C. W. Wu, S. Wang, C. N. Lam, H. Feng, J. Zhao, A. S. Cheng, K. F. To, H. L. Chan, and J. J. Sung (2010) Inhibitory role of peroxisome proliferator-activated receptor gamma in hepatocarcinogenesis in mice and in vitro. Hepatology 51: 2008-19. https://doi.org/10.1002/hep.23550
- Carnero, A. (2010) The PKB/AKT pathway in cancer. Curr. Pharm. Des. 16: 34-44. https://doi.org/10.2174/138161210789941865
- Wysocki, P. J. (2010) Targeted therapy of hepatocellular cancer. Expert Opin. Investig. Drugs 19: 265-74. https://doi.org/10.1517/13543780903514110
- Luo, Z., M. Zang, and W. Guo (2010) AMPK as a metabolic tumor suppressor: control of metabolism and cell growth. Future Oncol. 6: 457-70. https://doi.org/10.2217/fon.09.174
- Hien, T. T., H. G. Kim, E. H. Han, K. W. Kang, and H. G. Jeong (2010) Molecular mechanism of suppression of MDR1 by puerarin from Pueraria lobata via NF-kappaB pathway and cAMP-responsive element transcriptional activity-dependent up-regulation of AMP-activated protein kinase in breast cancer MCF-7/adr cells. Mol. Nutr. Food Res. 54: 918-28. https://doi.org/10.1002/mnfr.200900146
- Guo, W., E. Kong, and M. Meydani (2009) Dietary polyphenols, inflammation, and cancer. Nutr. Cancer 61: 807-10. https://doi.org/10.1080/01635580903285098
- Tachibana, H. (2009) Molecular basis for cancer chemoprevention by green tea polyphenol EGCG. Forum Nutr. 61: 156-69.
- Lopez-Lazaro M. (2009) Distribution and biological activities of the flavonoid luteolin. Mini Rev. Med. Chem. 9: 31-59. https://doi.org/10.2174/138955709787001712
- Lee, H. J., C. J. Wang, H. S. Kuo, F. P. Chou, L. F. Jean, and T. H. Tseng (2005) Induction apoptosis of luteolin in human hepatoma HepG2 cells involving mitochondria translocation of Bax/Bak and activation of JNK. Toxicol. Appl. Pharmacol. 203: 124-131. https://doi.org/10.1016/j.taap.2004.08.004
- Gradzka, I. (2006) Mechanisms and regulation of the programmed cell death. Postepy Biochem. 52: 157-65.
- Nishizuka, M. and M. Imagawa (2010) PPARgamma target genes and the molecular mechanism of transcriptional control by PPARgamma. Nippon Rinsho. 68: 189-93.
- Patel, L., I. Pass, P. Coxon, C. P. Downes, S. A. Smith, and C. H. Macphee (2001) Tumor suppressor and anti-inflammatory actions of PPAR-gamma agonists are mediated via upregulation of PTEN. Curr. Biol. 11: 764-8. https://doi.org/10.1016/S0960-9822(01)00225-1
- Farrow, B. and B. M. Evers (2003) Activation of PPARgamma increases PTEN expression in pancreatic cancer cells. Biochem. Biophys. Res. Commun. 301: 50-3. https://doi.org/10.1016/S0006-291X(02)02983-2
- Chen, W. C., M. S. Lin, and X. Bai (2005) Induction of apoptosis in colorectal cancer cells by peroxisome proliferators-activated receptor gamma activation up-regulating PTEN and inhibiting PI3K activity. Chin. Med. J. (Engl) 118: 1477-81.
- Lee, S. Y., G. Y. Hur, K. H. Jung, H. C. Jung, S. Y. Lee, J. H. Kim, C. Shin, J. J. Shim, K. H. In, K. H. Kang, and S. H. Yoo (2006) PPAR-gamma agonist increase gefi tinib's antitumor activity through PTEN expression. Lung Cancer 51: 297-301. https://doi.org/10.1016/j.lungcan.2005.10.010
- Giovannini, C., B. Scazzocchio, R. Varì, C. Santangelo, M. D'Archivio, and R. Masella (2007) Apoptosis in cancer and atherosclerosis: polyphenol activities. Ann. Ist. Super Sanita. 43: 406-16.
- Huang, C. H., S. J. Tsai, Y. J. Wang, M. H. Pan, J. Y. Kao, and T. D. Way (2009) EGCG inhibits protein synthesis, lipogenesis, and cell cycle progression through activation of AMPK in p53 positive and negative human hepatoma cells. Mol. Nutr. Food Res. 53: 1156-65. https://doi.org/10.1002/mnfr.200800592
- Puissant, A., G. Robert, N. Fenouille, F. Luciano, J. P. Cassuto, S. Raynaud, and P. Auberger (2010) Resveratrol promotes autophagic cell death in chronic myelogenous leukemia cells via JNK-mediated p62/SQSTM1 expression and AMPK activation. Cancer Res. 70: 1042-52. https://doi.org/10.1158/0008-5472.CAN-09-3537
- Lea, M. A., M. Sura, and C. Desbordes (2004) Inhibition of cell proliferation by potential peroxisome proliferatoractivated receptor (PPAR) gamma agonists and antagonists. Anticancer Res. 24: 2765-71.
- Horbinski, C. and C. T. Chu (2005) Kinase signaling cascades in the mitochondrion: a matter of life or death. Free Radic. Biol. Med. 38: 2-11. https://doi.org/10.1016/j.freeradbiomed.2004.09.030
- Maddika, S., S. R. Ande, S. Panigrahi, T. Paranjothy, K. Weglarczyk, A. Zuse, M. Eshraghi, K. D. Manda, E. Wiechec, and M. Los (2007) Cell survival, cell death and cell cycle pathways are interconnected: implications for cancer therapy. Drug Resist. Updat. 10: 13-29. https://doi.org/10.1016/j.drup.2007.01.003
- Kim, K. Y., A. Baek, J. E. Hwang, Y. A. Choi, J. Jeong, M. S. Lee, D. H. Cho, J. S. Lim, K. I. Kim, and Y. Yang (2009) Adiponectin-activated AMPK stimulates dephosphorylation of AKT through protein phosphatase 2A activation. Cancer Res. 69: 4018-26.